Table 4.

Therapeutic drug and target value achievement rates of the wild-type and rs78466831 patients with T2DM.

Variables(%)	wide-type	rs78466831	P-value
Oral agents (hypoglycemic drug )	128/148	6/6	0.192
Insulin (hypoglycemic drug )	112/148	6/6	0.337
FBG(4.4‐7.0 mmol)	46/148	3/6	0.383
HbA1c (<7.0%)	42/148	1/6	0.463
TC(<4.5 mmol/L)	75/148	2/6	0.681
HDL-C (>1.0 mmol/L men or >1.3 mmol/L women)	101/148	5/6	0.666
TG(<1.7 mmol/L)	89/148	2/6	0.227
LDL-C(<2.6 mmol/L ,not accompanied by CHD or <1.8 mmol/L, accompanied by CHD))	66/148	1/6	0.234
BMI ( <24 kg/m2)	90/148	5/6	0.255